Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1966 1
1967 1
1968 1
1969 1
1970 1
1971 2
1972 1
1973 3
1974 1
1976 3
1977 2
1978 3
1980 3
1981 1
1982 4
1984 1
1985 2
1987 3
1988 6
1989 4
1990 3
1991 11
1992 16
1993 8
1994 14
1995 11
1996 6
1997 12
1998 9
1999 17
2000 19
2001 16
2002 17
2003 10
2004 21
2005 38
2006 59
2007 84
2008 59
2009 78
2010 101
2011 123
2012 112
2013 113
2014 134
2015 112
2016 120
2017 105
2018 142
2019 144
2020 180
2021 221
2022 184
2023 184
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

2,258 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.
Roofeh D, Lin CJF, Goldin J, Kim GH, Furst DE, Denton CP, Huang S, Khanna D; focuSSced Investigators. Roofeh D, et al. Arthritis Rheumatol. 2021 Jul;73(7):1301-1310. doi: 10.1002/art.41668. Epub 2021 May 25. Arthritis Rheumatol. 2021. PMID: 33538094 Free PMC article. Clinical Trial.
For mild, moderate, and severe QILD, the mean SD change in FVC% in the TCZ arm at 48 weeks were -4.1 2.5% (n = 11), 0.7 1.9% (n =19), and 2.1 1.6% (n = 26), respectively, and in the placebo group were -10.0 2.6% (n = 11), -5.7 1.6% (n = 26), and …
For mild, moderate, and severe QILD, the mean SD change in FVC% in the TCZ arm at 48 weeks were -4.1 2.5% (n = 11), 0.7 1.9% (n
Reply.
Bernstein EJ, Khanna D, Lederer DJ. Bernstein EJ, et al. Arthritis Rheumatol. 2019 Feb;71(2):327-328. doi: 10.1002/art.40762. Epub 2018 Dec 29. Arthritis Rheumatol. 2019. PMID: 30346112 Free article. No abstract available.
Re; Seniaray N, Verma R, Khanna S, Belho E, Pruthi A, Mahajan H. Localization and restaging of carcinoma prostate by 68Gallium prostate-specific membrane antigen positron emission tomography computed tomography in patients with biochemical recurrence. Indian J Urol 2020;36:191-9.
Pandey A, Mandal S, Das MK, Nayak P. Pandey A, et al. Indian J Urol. 2020 Oct-Dec;36(4):337-338. doi: 10.4103/iju.IJU_428_20. Epub 2020 Oct 1. Indian J Urol. 2020. PMID: 33376282 Free PMC article. No abstract available.
Oral Nutritional Supplementation Improves Growth in Children at Malnutrition Risk and with Picky Eating Behaviors.
Khanna D, Yalawar M, Saibaba PV, Bhatnagar S, Ghosh A, Jog P, Khadilkar AV, Kishore B, Paruchuri AK, Pote PD, Mandyam RD, Shinde S, Shah A, Huynh DTT. Khanna D, et al. Nutrients. 2021 Oct 14;13(10):3590. doi: 10.3390/nu13103590. Nutrients. 2021. PMID: 34684591 Free PMC article. Clinical Trial.
The present study aimed to determine the effects of ONS along with DC on growth in comparison with the effects of DC only. Enrolled children (N = 321) were >24 to 48 months old, at malnutrition risk (weight-for-height percentile 3rd to 15th), and described as a picky ea …
The present study aimed to determine the effects of ONS along with DC on growth in comparison with the effects of DC only. Enrolled children …
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.
Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R; American College of Rheumatology. Khanna D, et al. Arthritis Care Res (Hoboken). 2012 Oct;64(10):1431-46. doi: 10.1002/acr.21772. Arthritis Care Res (Hoboken). 2012. PMID: 23024028 Free PMC article. No abstract available.
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.
Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Lioté F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R; American College of Rheumatology. Khanna D, et al. Arthritis Care Res (Hoboken). 2012 Oct;64(10):1447-61. doi: 10.1002/acr.21773. Arthritis Care Res (Hoboken). 2012. PMID: 23024029 Free PMC article. No abstract available.
New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis.
Khanna D, Huang S, Lin CJF, Spino C. Khanna D, et al. Ann Rheum Dis. 2021 May;80(5):641-650. doi: 10.1136/annrheumdis-2020-219100. Epub 2020 Nov 30. Ann Rheum Dis. 2021. PMID: 33257497 Free PMC article.
Risk differences (RDs) between active and placebo treatments were calculated by averaging over the replicate datasets; bootstrap 95% CIs for the RDs to estimate the magnitude of treatment effects. RESULTS: In the development sets (n=237), the proportion of participants in …
Risk differences (RDs) between active and placebo treatments were calculated by averaging over the replicate datasets; bootstrap 95% CIs for …
The Ocular Gene Delivery Landscape.
Sahu B, Chug I, Khanna H. Sahu B, et al. Biomolecules. 2021 Aug 1;11(8):1135. doi: 10.3390/biom11081135. Biomolecules. 2021. PMID: 34439800 Free PMC article. Review.
Coordinating Synaptic Signaling with CRMP2.
Stratton H, Boinon L, Moutal A, Khanna R. Stratton H, et al. Int J Biochem Cell Biol. 2020 Jul;124:105759. doi: 10.1016/j.biocel.2020.105759. Epub 2020 May 8. Int J Biochem Cell Biol. 2020. PMID: 32437854 Review.
CRMP2 is a synaptic protein, expressed at pre- and post-synaptic sites. Interactions with proteins such as N-methyl-D-aspartate receptors, syntaxin1A as well as voltage-gated calcium and sodium channels, suggest that CRMP2 may control both the electrical and chemical compo …
CRMP2 is a synaptic protein, expressed at pre- and post-synaptic sites. Interactions with proteins such as N-methyl-D-aspartate recep …
2,258 results